Researchers have found in the phase II SOLSTICE trial that the investigational combination of tobevibart plus elebsiran ...

Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB) Authors ...

Antiviral Gene Therapy Research Unit (AGTRU) has the following research output in the current window (1 July 2024 - 30 June 2025) of the Nature Index. Click on Count to view a list of articles ...

SAN FRANCISCO, CA—December 9, 2021—As the SARS-CoV-2 virus mutates, new variants emerge that can better evade immunity and spread more widely. This causes an ongoing race, in which scientists and ...

cirrhosis of liver with chronic hepatitis The finding of a reduce risk of cirrhosis in patients with chronic HBV on antiviral therapy underscores the importance of early treatment. Patients with ...

Severe acute respiratory coronavirus 2 (SARS-CoV-2) has affected millions with coronavirus disease 2019 (COVID-19). Despite vaccines being available to prevent severe disease and hospitalization, ...

Bottom Line: Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and safety in a phase ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its investigational novel COVID-19 oral antiviral candidate, PAXLOVID™, significantly reduced hospitalization and death, based on an ...

Please provide your email address to receive an email when new articles are posted on . HBV birth dose vaccination with antiviral prophylaxis in pregnant women with high viral load could avert 1.1 ...